Cargando…
Zelquistinel Is an Orally Bioavailable Novel NMDA Receptor Allosteric Modulator That Exhibits Rapid and Sustained Antidepressant-Like Effects
BACKGROUND: The role of glutamatergic receptors in major depressive disorder continues to be of great interest for therapeutic development. Recent studies suggest that both negative and positive modulation of N-methyl-D-aspartate receptors (NMDAR) can produce rapid antidepressant effects. Here we re...
Autores principales: | Burgdorf, Jeffrey S, Zhang, Xiao-Lei, Stanton, Patric K, Moskal, Joseph R, Donello, John E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743962/ https://www.ncbi.nlm.nih.gov/pubmed/35882204 http://dx.doi.org/10.1093/ijnp/pyac043 |
Ejemplares similares
-
Positive N-Methyl-D-Aspartate Receptor Modulation by Rapastinel Promotes Rapid and Sustained Antidepressant-Like Effects
por: Donello, John E, et al.
Publicado: (2018) -
The Development of Rapastinel (Formerly GLYX-13); A Rapid Acting and Long Lasting Antidepressant
por: Moskal, Joseph R., et al.
Publicado: (2017) -
NYX-2925 Is a Novel NMDA Receptor-Specific Spirocyclic-β-Lactam That Modulates Synaptic Plasticity Processes Associated with Learning and Memory
por: Khan, M Amin, et al.
Publicado: (2017) -
Positive Emotional Learning Induces Resilience to Depression: A Role for NMDA Receptor-mediated Synaptic Plasticity
por: Burgdorf, Jeffrey, et al.
Publicado: (2017) -
IGFBP2 Produces Rapid-Acting and Long-Lasting Effects in Rat Models of Posttraumatic Stress Disorder via a Novel Mechanism Associated with Structural Plasticity
por: Burgdorf, Jeffrey, et al.
Publicado: (2017)